Breast Ptosis Clinical Trial
Official title:
A Post-Market Study of a Minimally Invasive Beast Lift Procedure Utilizing the Renuvion APR System
This is a prospective, non-randomized, single-center, evaluator blinded study of up to 15 subjects undergoing a minimally invasive breast lift procedure utilizing the Renuvion APR System. Subjects will receive treatment with the Renuvion APR System to both breasts.
This is a prospective, non-randomized, single-center, evaluator blinded study of up to 15 subjects undergoing a minimally invasive breast lift procedure utilizing the Renuvion APR System. Subjects will receive treatment with the Renuvion APR System to both breasts. At baseline, the grade of breast ptosis, breast measurements and pre-surgery photographs will be taken using the site's camera system. Procedure data and adverse events will be captured. Follow-up visits will occur at 30, 90, and 180-days post-procedure. Subjects may also be seen back for follow-up at the investigator's discretion. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00775788 -
Autologous Fat Grafting to the Breast
|
N/A | |
Completed |
NCT00959374 -
Evaluation of Dermal Closure With an Absorbable Barbed Suture as Compared to a Conventional Absorbable Suture
|
N/A | |
Completed |
NCT06262724 -
Breast Reshaping Following Massive Weight Loss
|
N/A | |
Withdrawn |
NCT00774059 -
Evaluation of Safety and Performance of the Orbix Breast Lift System
|
N/A |